Extraintestinal Manifestations and Family History of Inflammatory Bowel Disease Increase the Risk of Pouchitis in a State-Level Epidemiology Study
Authors:
- Edward L. BarnesEBEdward L. Barnes
- Michael S. DunnMDMichael S. Dunn
- Jean AshburnJAJean Ashburn
- Amy BartoABAmy Barto
- Richard BloomfeldRBRichard Bloomfeld
- Ashley CairnsACAshley Cairns
- Kurren MehtaKMKurren Mehta
- Pooja PatelPPPooja Patel
- Jennifer DziwisJDJennifer Dziwis
- Scott EsckilsenSEScott Esckilsen
- Reza RahbarRRReza Rahbar
- Timothy S. SadiqTSTimothy S. Sadiq
Open Access
- 26 December 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 15 (2) , e00670
Abstract
INTRODUCTION: Our understanding of the epidemiology of inflammatory conditions of the pouch and effectiveness of treatment is largely based on selected populations. We created a state-level registry to evaluate the incidence of pouchitis and the effectiveness of treatments used in an initial episode of pouchitis. METHODS: In a state-level retrospective cohort of all patients undergoing proctocolectomy with ileal pouch-anal anastomosis (IPAA) for ulcerative colitis between January 1, 2018, and December 31, 2020, we evaluated the incidence of pouchitis and compared the proportion of patients developing recurrent pouchitis and chronic antibiotic-dependent pouchitis according to initial antibiotic therapy. RESULTS: A total of 177 patients underwent surgery with 49 (28%) developing pouchitis within the 12 months after the final stage of IPAA. Patients with extraintestinal manifestations of inflammatory bowel disease (IBD) were significantly more likely to develop pouchitis within the first 12 months after IPAA (adjusted odds ratio 2.45, 95% confidence interval 1.03–5.81) after adjusting for family history of IBD (adjusted odds ratio 3.50, 95% 1.50–8.18). When comparing the proportion of patients who developed recurrent pouchitis or chronic antibiotic-dependent pouchitis with those who experienced an isolated episode of pouchitis, there were no significant differences among the initial antibiotic regimens used. DISCUSSION: In a state-level examination of outcomes after IPAA for ulcerative colitis, patients with extraintestinal manifestations of IBD were more likely to develop pouchitis; however, the initial antibiotic regimen chosen did not seem to affect long-term outcomes.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK127157)
This publication has 44 references indexed in Scilit:
- Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosisInflammatory Bowel Diseases, 2008
- A Prospective Multivariate Analysis of Clinical Factors Associated With Pouchitis After Ileal Pouch–Anal AnastomosisClinical Gastroenterology and Hepatology, 2007
- Results at up to 20 years after ileal pouch–anal anastomosis for chronic ulcerative colitisBritish Journal of Surgery, 2007
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006
- Risk Factors for Diseases of Ileal Pouch–Anal Anastomosis After Restorative Proctocolectomy for Ulcerative ColitisClinical Gastroenterology and Hepatology, 2006
- Differentiating risk factors for acute and chronic pouchitisClinical Gastroenterology and Hepatology, 2005
- Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysisScandinavian Journal of Gastroenterology, 2003
- A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute PouchitisInflammatory Bowel Diseases, 2001
- Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.Gut, 1996
- IIeal Pouch-Anal Anastomoses Complications and Function in 1005 PatientsAnnals of Surgery, 1995